These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16382002)

  • 1. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
    Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
    Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukins 6 and 8 and abdominal fat depots are distinct correlates of lipid moieties in healthy pre- and postmenopausal women.
    Veldhuis JD; Dyer RB; Trushin SA; Bondar OP; Singh RJ; Klee GG
    Endocrine; 2016 Dec; 54(3):671-680. PubMed ID: 27444747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
    Thunell L; Andersson B; Glassell M; Mattsson LA
    Maturitas; 2006 Mar; 53(4):430-8. PubMed ID: 16198072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
    Dobs AS; Nguyen T; Pace C; Roberts CP
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus.
    Andersson B; Mattsson LA; Hahn L; Mårin P; Lapidus L; Holm G; Bengtsson BA; Björntorp P
    J Clin Endocrinol Metab; 1997 Feb; 82(2):638-43. PubMed ID: 9024268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women.
    Maturana MA; Moreira RM; Spritzer PM
    Maturitas; 2011 Dec; 70(4):395-9. PubMed ID: 22018728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women.
    Kim JW; Kim DY
    Metab Syndr Relat Disord; 2012 Dec; 10(6):452-7. PubMed ID: 22989086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat mass and obesity-associated gene polymorphisms do not affect metabolic response to hormone therapy in healthy postmenopausal women.
    Ramos RB; Casanova GK; Spritzer PM
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):302-6. PubMed ID: 22901973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
    Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
    Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise.
    Tymchuk CN; Tessler SB; Barnard RJ
    Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.